629 - A novel efficacy index for long-term therapy outcomes expressed by maintenance of EASI 75 and IGA 0,1 response in atopic dermatitis.

MLA

Silverberg, Jonathan I., et al. “629 - A Novel Efficacy Index for Long-Term Therapy Outcomes Expressed by Maintenance of EASI 75 and IGA 0,1 Response in Atopic Dermatitis.” British Journal of Dermatology, vol. 191, Aug. 2024, pp. 1–2. EBSCOhost, https://doi.org/10.1093/bjd/ljae266.013.

APA

Silverberg, J. I., Irvine, A., Foley, P., Rosso, J. D., Schacht, A., Dossenbach, M., Casillas, M., Johansson, E., Gallo, G., & Gold, L. S. (2024). 629 - A novel efficacy index for long-term therapy outcomes expressed by maintenance of EASI 75 and IGA 0,1 response in atopic dermatitis. British Journal of Dermatology, 191, 1–2. https://doi.org/10.1093/bjd/ljae266.013

Chicago

Silverberg, Jonathan I, Alan Irvine, Peter Foley, James Del Rosso, Alexander Schacht, Martin Dossenbach, Marta Casillas, Erin Johansson, Gaia Gallo, and Linda Stein Gold. 2024. “629 - A Novel Efficacy Index for Long-Term Therapy Outcomes Expressed by Maintenance of EASI 75 and IGA 0,1 Response in Atopic Dermatitis.” British Journal of Dermatology 191 (August): 1–2. doi:10.1093/bjd/ljae266.013.